Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve N Caritis

Showing results (21-30 of 283) with videos related to

Pageof 29
Sort By:
American Journal of Obstetrics and Gynecology|February 22, 2019
ReplyAlisse Hauspurg, Lara Lemon, Raman Venkataramanan, et al.
American Journal of Perinatology|November 16, 2021
A Possible Mechanism of Action of 17α-Hydroxyprogesterone Caproate: Enhanced IL-10 ProductionChristina J Megli, Alisse Hauspurg, Raman Venkataramanan, et al.
British Journal of Clinical Pharmacology|July 9, 2017
A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administrationHari V Kalluri, Hongfei Zhang, Steve N Caritis, et al.
Hypertension (Dallas, Tex. : 1979)|May 27, 2018
Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk CohortAlisse Hauspurg, Elizabeth F Sutton, Janet M Catov, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 19, 2012
A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MSVenkateswaran C Pillai, Stephen C Strom, Steve N Caritis, et al.
American Journal of Obstetrics and Gynecology|February 8, 2005
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancyTimothy S Tracy, Raman Venkataramanan, Douglas D Glover, et al.
American Journal of Obstetrics and Gynecology|April 26, 2024
The dosing regimen for 17-hydroxyprogesterone caproate was suboptimal: lessons for future pharmacotherapy for pregnant womenSteve N Caritis, Prerna Dodeja, Shringi Sharma, et al.
American Journal of Obstetrics and Gynecology|November 9, 2013
Quality assessment of compounded 17-hydroxyprogesterone caproateJustine Chang, Yang Zhao, Wenchen Zhao, et al.
Obstetrics and Gynecology|April 8, 2016
Ondansetron Use in PregnancyLara L Siminerio, Lisa M Bodnar, Raman Venkataramanan, et al.
American Journal of Obstetrics and Gynecology|October 22, 2008
Maternal and fetal Toll-like receptor 4 genotype and chorionic plate inflammatory lesionsHyagriv N Simhan, Trevor MacPherson, Steve N Caritis, et al.
Pageof 29

Showing results (21-30 of 283) with videos related to

Sort By:
Pageof 29
American Journal of Obstetrics and Gynecology|February 22, 2019
ReplyAlisse Hauspurg, Lara Lemon, Raman Venkataramanan, et al.
American Journal of Perinatology|November 16, 2021
A Possible Mechanism of Action of 17α-Hydroxyprogesterone Caproate: Enhanced IL-10 ProductionChristina J Megli, Alisse Hauspurg, Raman Venkataramanan, et al.
British Journal of Clinical Pharmacology|July 9, 2017
A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administrationHari V Kalluri, Hongfei Zhang, Steve N Caritis, et al.
Hypertension (Dallas, Tex. : 1979)|May 27, 2018
Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk CohortAlisse Hauspurg, Elizabeth F Sutton, Janet M Catov, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 19, 2012
A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MSVenkateswaran C Pillai, Stephen C Strom, Steve N Caritis, et al.
American Journal of Obstetrics and Gynecology|February 8, 2005
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancyTimothy S Tracy, Raman Venkataramanan, Douglas D Glover, et al.
American Journal of Obstetrics and Gynecology|April 26, 2024
The dosing regimen for 17-hydroxyprogesterone caproate was suboptimal: lessons for future pharmacotherapy for pregnant womenSteve N Caritis, Prerna Dodeja, Shringi Sharma, et al.
American Journal of Obstetrics and Gynecology|November 9, 2013
Quality assessment of compounded 17-hydroxyprogesterone caproateJustine Chang, Yang Zhao, Wenchen Zhao, et al.
Obstetrics and Gynecology|April 8, 2016
Ondansetron Use in PregnancyLara L Siminerio, Lisa M Bodnar, Raman Venkataramanan, et al.
American Journal of Obstetrics and Gynecology|October 22, 2008
Maternal and fetal Toll-like receptor 4 genotype and chorionic plate inflammatory lesionsHyagriv N Simhan, Trevor MacPherson, Steve N Caritis, et al.
Pageof 29